Provided by Tiger Fintech (Singapore) Pte. Ltd.

C4 Therapeutics, Inc.

1.73
+0.260017.69%
Post-market: 1.67-0.0600-3.47%19:54 EDT
Volume:1.28M
Turnover:2.14M
Market Cap:122.84M
PE:-1.17
High:1.75
Open:1.50
Low:1.50
Close:1.47
Loading ...

C4 Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
07 May

C4 Therapeutics Q1 2025 EPS $(0.37) Beats $(0.47) Estimate, Sales $7.24M Beat $4.45M Estimate

Benzinga
·
07 May

BRIEF-C4 Therapeutics Q1 EPS USD -0.37

Reuters
·
07 May

C4 Therapeutics Q1 Revenue USD 7.2 Million

THOMSON REUTERS
·
07 May

Changi Airport Terminal 5 contracts worth S$4.75 billion awarded

businesstimes
·
06 May

C4 Therapeutics Inc expected to post a loss of 45 cents a share - Earnings Preview

Reuters
·
02 May

CCCC Releases 2025 Q1 Unaudited Financial Report

TIPRANKS
·
27 Apr

April 2025's Standout Penny Stocks

Simply Wall St.
·
23 Apr

CCCC Design & Consulting Group 2024 Profit Down 0.8%, Revenue Slips 8%

MT Newswires Live
·
28 Mar

C4 Therapeutics (CCCC) Loses -21.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks
·
03 Mar

UBS Adjusts C4 Therapeutics Price Target to $3.50 From $4, Maintains Neutral Rating

MT Newswires Live
·
03 Mar

C4 Therapeutics: Promising Clinical Developments and Strategic Plans Justify Buy Rating

TIPRANKS
·
02 Mar

C4 Therapeutics Reports Strong 2024 Financial Performance and Clinical Progress

TIPRANKS
·
28 Feb

C4 Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Feb

C4 Therapeutics, Inc. (CCCC) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
27 Feb

C4 Therapeutics Inc: Cash, Cash Equivalents and Marketable Securities of $267.3 Mln as of Dec 31, 2024; Expected to Provide Runway Into 2027

THOMSON REUTERS
·
27 Feb

C4 Therapeutics Inc Q4 Shr View $-0.48 -- Lseg Ibes Data

THOMSON REUTERS
·
27 Feb

C4 Therapeutics Inc: Qtrly Loss per Share $0.49

THOMSON REUTERS
·
27 Feb

C4 Therapeutics (CCCC) Loses -23.14% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks
·
26 Feb

C4 Therapeutics Inc expected to post a loss of 48 cents a share - Earnings Preview

Reuters
·
24 Feb